Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $351.91 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| 3B Medical, Inc. | $149.11 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $147.04 | 5 | $0 (2024) |
| ABBVIE INC. | $39.02 | 2 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $16.74 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $204.81 | 4 | 3B Medical, Inc. ($149.11) |
| 2023 | $41.18 | 2 | Novartis Pharmaceuticals Corporation ($41.18) |
| 2022 | $13.44 | 1 | Novartis Pharmaceuticals Corporation ($13.44) |
| 2018 | $16.74 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($16.74) |
| 2017 | $75.74 | 1 | Novartis Pharmaceuticals Corporation ($75.74) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | 3B Medical, Inc. | LUNA (Device) | Food and Beverage | Cash or cash equivalent | $149.11 | General |
| Category: VENTILATOR, NON-CONTINUOUS (RESPIRATOR) | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/07/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/15/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO, AVYCAZ | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/02/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/08/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/19/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/28/2018 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.74 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/01/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $75.74 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 397 | 655 | $124,561 | $45,525 |
| 2022 | 8 | 354 | 551 | $102,488 | $37,878 |
| 2021 | 5 | 294 | 556 | $101,538 | $37,996 |
| 2020 | 11 | 455 | 786 | $156,879 | $58,651 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 145 | 339 | $57,240 | $20,673 | 36.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 150 | 160 | $38,336 | $14,244 | 37.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 75 | 77 | $22,479 | $7,520 | 33.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 27 | 79 | $6,506 | $3,088 | 47.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 125 | 295 | $43,713 | $16,369 | 37.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 91 | 94 | $20,485 | $7,502 | 36.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 34 | 35 | $14,321 | $5,075 | 35.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 22 | 23 | $6,489 | $2,475 | 38.1% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 23 | 23 | $6,390 | $2,341 | 36.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 20 | 22 | $4,746 | $1,793 | 37.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 21 | 23 | $3,412 | $1,216 | 35.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 18 | 36 | $2,932 | $1,108 | 37.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 132 | 387 | $58,585 | $22,203 | 37.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 99 | 105 | $23,306 | $8,827 | 37.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 25 | 25 | $10,593 | $3,905 | 36.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 22 | 23 | $6,643 | $2,168 | 32.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 16 | 16 | $2,411 | $893.55 | 37.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 146 | 451 | $71,258 | $26,542 | 37.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 95 | 105 | $24,422 | $9,178 | 37.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 50 | 50 | $21,987 | $8,217 | 37.4% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 22 | 23 | $9,255 | $3,510 | 37.9% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2020 | 23 | 25 | $7,393 | $2,778 | 37.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 38 | 41 | $6,478 | $2,371 | 36.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 18 | 18 | $5,291 | $2,023 | 38.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 16 | 19 | $4,126 | $1,500 | 36.4% |
About Dr. Brian Stiltner, D.O
Dr. Brian Stiltner, D.O is a Hospitalist healthcare provider based in Abingdon, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2011. The National Provider Identifier (NPI) number assigned to this provider is 1356638076.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Stiltner, D.O has received a total of $351.91 in payments from pharmaceutical and medical device companies, with $204.81 received in 2024. These payments were reported across 9 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($351.91).
As a Medicare-enrolled provider, Stiltner has provided services to 1,500 Medicare beneficiaries, totaling 2,548 services with total Medicare billing of $180,049. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine
- Location Abingdon, VA
- Active Since 07/01/2011
- Last Updated 03/14/2024
- Taxonomy Code 208M00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1356638076
Products in Payments
- LUNA (Device) $149.11
- ENTRESTO (Drug) $147.04
- TEFLARO (Drug) $19.79
- DALVANCE (Drug) $19.23
- LifeVest (Device) $16.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.